Metabolic and histologic effects of recombinant canine somatotropin on bone healing in dogs, using an unstable ostectomy gap model

American Journal of Veterinary Research

Volumn 57, Issue 9, 1996, Pages 1395-1401

  Wilkens, Brent E ^a,c   Millis, Darryl L ^a   Daniel, Gregory B ^a   Munson, Linda ^a   Patel, Kanaiyala R ^b   Buonomo, Frances C ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b MONSANTO COMPANY   (United States)

^c Metroplex Veterinary Centre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OSTEOCALCIN; RECOMBINANT PROTEIN; SOMATOMEDIN C;

ANIMAL; ARTICLE; BLOOD; DOG; DRUG EFFECT; FEMALE; FRACTURE HEALING; PATHOLOGY; RADIUS; TIME;

ANIMALS; DOGS; FEMALE; FRACTURE HEALING; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; OSTEOCALCIN; RADIUS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0030228442     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Brinker WO, Piermattei DL, Flo GL. Fractures: classification, diagnosis and treatment. In: Handbook of small animal orthopedics and fracturc treatment. Philadelphia: WB Saunders Co, 1990;3-58.
2. Einhorn TA. Enhancement of fracture-healing. J Bone Joint Surg 1995;77A:940-956.
3. Heckman JD, Boyan BD, Aufdemorte TB, et al. The use of bone morphogenic protein in the treatment of non-union in a canine model. J Bone Joint Surg 1991;73A:750-764.
4. Hsu JD, Robinson RA. Studies on the healing of long bone fractures in hereditary pituitary insufficient mice. J Surg Res 1969;9:535-536.
5. Misol S, Samaan N, Ponseti N. GH in delayed fracture union. Clin Orthop 1971;74:206-209.
6. Nielsen HM, Bak B, Jorgensen PH, et al. Growth hormone promotes healing of tibial fractures in the rat. Acta Orthop Scand 1991;62:244-247.
7. Animal Welfare Act of 1976. 9 CFR subchapter A, parts 1, 2, and 3.
8. Fanti P, Colombo G, Yao C, et al. Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin. J Bone Miner Res 1993;8:745-752.
9. Muller J, Schenk R, Willenegger H. Experimentelle Untersuchungen uber die entstehung reaktiver pseudarthrosen am hunderadins. Helv Chir Acta 1968;35:301-308.
10. Wuster C. Growth hormone and bone metabolism. Acta Endocrinol 1993;128:14-18.
11. Verhaeghe J, Bouillon R. Actions of insulin and the IGFs on bone. News Physiol Sci 1994;9:20-22.
12. Johannson AG, Lindh E, Ljunghall S. IGFs: function and clinical importance: growth hormone, insulin-like growth factor 1 and bone: a clinical review. J Intern Med 1993;234:553-560.
13. Leung DW, Spencer SA. Cachines, et al. Growth hormone receptor and serum hinding protein: purification, cloning and expression. Nature 1987;330:537-543.
14. Stracke H, Schulz A, Rossol R, et al. Effect of growth hormone on ostcoblasts and demonstration of somatomedin C: IGF-I in bone organ culture. Acta Endocrinol 1984;107:16-24.
15. Ernst M, Froesch ER. Growth hormone dependent stimulation of ostcoblasl-like cells in serum free cultures via local synthesis of insulin-like growth factor I. Bioehcm Biophys Res Commun 1988;151:142-147.
16. Canalis E. Effect of insulin-like growth factor 1 on DNA and protein synthesis in cultured rat calvariae. J Clin Invest 1980;66:709-717
17. Fournier B, Ferralli J, Price P, et al. Comparison of the effects of insulin-like growth factors I and II on the human osteosarcoma cell line OHS-4. J Endocrinol 1993;136:173-180.
18. Lian JB, Gundberg CM. Osteocalcin: biochemical considerations and clinical applications. Clin Orthop 1988;226:267-291.
19. Lian JB, Couttes MC, Canalis E. Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvaria. J Biol Chem 1985;260:8706.
20. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991;28:287-335.
21. Mallmin H, Ljunghall S, Larsson K. Biochemical markers of bone metabolism in patients with fracture of the distal forearm. Clin Orthop 1993;295:259-263.
22. Nyman MT, Paavolainen P, Forsius S, et al. Clinical evaluation of fracture healing by serum osteocalcin and alkaline phosphatase. Ann Chir Cynaecol 1991;80:289-293.
23. Cole DE, Carpenter TO, Gundberg CM. Serum OST levels in children with metabolic bone disease. J Prdiatr 1985;106:770.
24. Weinstein RS, Gundherg CM. Serum osteocalcin levels reflect bone mineralization in ostcopenic patients. Clin Res 1983;31:853.
25. Delmas PD, Chatelain P, Malaval L, et al. Serum hone Glaprotein in growth hormone deficient children. J Bone Miner Res 1986;1:333.
26. Brixen K, Nielsen H, Eriksen L, et al. Efficacy of wheat germ lectin-precipilated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum hone Gla protein. Calcif Tissue Int 1989;44:93.
27. Seino Y, Kanzaki S, Kubo T, et al. Serum levels of intact osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy. Nippon Naibunpi Gakkai 1994;70:1063-1074.
28. Smith MA, Jones HA, Strachan RK, et al. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg 1987;69B:441-447.
29. Auchinloss JM, Watt I. Scintigraphy in the evaluation of potential fracture healing: a clinical study of tibial fractures. Br J Radiol 1982;55:707-713.
30. Markel MD, Snyder JR, Hornof WJ, et al. Nuclear scintigraphic evaluation of third metacarpal and metatarsal hone fractures in three horses. J Am Vet Med Assoc 1987;191:75-77.
31. 99mTc pyrophosphate scintigraphy. J Am Anim Hosp Assor 1979;15:319-322.
32. Selcer BA. Imaging: bone. Vet Radiol 1983;24:243-250.
33. Azain MJ, Kasser TR, Sabaeky MJ. Composition for controlled release of polypeptides. Eur Patent Appl 1989;374:120.